how are companies still selling compounded semaglutide Despite FDA ruling, GLP-1s giving Novo and Lilly headaches on the market FDA is moving to restrict

"Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal"

A recent study projected that people who stop taking GLP-1s would regain their lost weight within about 18 months

In this case, the dynamics really do favour Lilly, and I expect the compounded tirzepatide market to shrink meaningfully over the next two years as pricing converges

Mitochondrial membrane potential assay INS-1 832/3 cells were seeded in 35-mm glass-bottom dishes (MatTek), incubated in 3 mM glucose KRBH for 1 hour, followed by incubation with 50 M tetramethylrhodamine (TMRE) in 3 mM glucose KRBH for 15 minutes to label active mitochondria 99

Food and Drug Administration approved the drug under the name Byetta

Villaschi A, Ferrante G, Cannata F, Pini D, Pagnesi M, Corrada E, et al